San Diego, CA, United States of America

Larry Kenneth Truesdale


Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 181(Granted Patents)


Location History:

  • Chester Springs, PA (US) (1995)
  • San Diego, CA (US) (2001 - 2005)

Company Filing History:


Years Active: 1995-2005

Loading Chart...
7 patents (USPTO):Explore Patents

Certainly! Here is an article about inventor Larry Kenneth Truesdale:

Title: Innovator Spotlight: Larry Kenneth Truesdale

Introduction:

Larry Kenneth Truesdale is a prolific inventor based in San Diego, California. With a strong background in pharmaceuticals, Truesdale has made significant contributions to the field of medicine through his innovative patents.

Latest Patents:

Truesdale's latest patents include Non-peptide GLP-1 agonists, which are novel compounds used in the treatment of metabolic disorders such as Type 1 and Type 2 diabetes. He has also patented Glucagon antagonists/inverse agonists, a class of compounds that counteract the effects of the glucagon hormone, making them valuable in the treatment of conditions like hyperglycemia and obesity.

Career Highlights:

Truesdale has worked with renowned companies such as Novo Nordisk A/S, where he has been instrumental in developing cutting-edge pharmaceutical solutions. His work has helped advance the field of medicine and improve treatment options for patients with various health conditions.

Collaborations:

Throughout his career, Truesdale has collaborated closely with industry experts such as Jesper F Lau and Peter Madsen. Together, they have pushed the boundaries of pharmaceutical research and development, leading to groundbreaking innovations in the field.

Conclusion:

Larry Kenneth Truesdale's dedication to innovation and his strategic collaborations have positioned him as a key figure in the pharmaceutical industry. His patents continue to impact the lives of many, offering new hope for the treatment and prevention of a range of diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…